Latest News
De Novo Antibody Sequencing: Which Enzymes are Best?
De novo antibody sequencing is the process of determining the primary amino acid sequence of an antibody directly from the protein. Determining the sequence of an antibody is a requirement for many downstream activities. Intellectual Property Protection: In order to...
VHH De Novo Antibody Sequencing
VHHs are 15kDa proteins that represent the antigen binding portion of heavy chain-only antibodies (HCAb) from llamas and alpacas. Their small size and stability make them ideal components of therapeutics such as bispecific antibodies or CAR-T therapies. In addition,...
Abterra Bio awarded $1.8M NIH SBIR to extend antibody repertoire analysis software, REPTOR
Next-generation sequencing is a valuable readout for antibody discovery campaigns, but current software does not address the real pain points of analysis. Abterra Biosciences has developed Reptor software to enable visualization and interrogation of large-scale...
Abterra Opens Its Doors To Celebrate New Location With Open House
Celebrating milestones is an important part of our personal and professional journeys. We wanted to commemorate this exciting new chapter in Abterra's story with the people who mean the most to us: our devoted employees, cherished families, esteemed investors, and...
Abterra Bio Has Moved To Sorrento Valley
Abterra Bio Has Moved To Sorrento Valley In 2009, Abterra Bio began as Digital Proteomics LLC, a spin-out of the University of California – San Diego. Founders Pavel Pevzner and Vineet Bafna, as well as Natalie Castellana, Stefano Bonissone, and Anand Patel have been...
PEGS Boston Summit 2021 Presentation
Abstract: Next-generation sequencing of antibody repertoires has provided new insights into natural immune responses. The correlation between the B-cell receptor repertoire and the serological antibody repertoire has only been analyzed in a small number of studies. ...
Other Categories
Get In Touch